Beta-Lactams, Macrolides & Quinolones: Antibiotic Guide

Most antibiotics in everyday use belong to four great families. Beta-lactams (penicillins, cephalosporins, carbapenems) destroy the bacterial cell wall, macrolides (erythromycin, azithromycin) jam the bacterial protein factory at the 50S ribosome subunit, aminoglycosides (gentamicin, amikacin) corrupt protein building at the 30S subunit, and quinolones (ciprofloxacin, levofloxacin) tangle bacterial DNA by blocking the enzymes that unwind it.

This matters because choosing the right family decides whether an infection is cured or the bacteria survive to become resistant. A urinary infection, a pneumonia and a typhoid fever each demand a different class, and using the wrong one wastes precious days. For MBBS students, these four classes are the backbone of antimicrobial pharmacology and of every ward prescription.

Key Concepts

• Beta-lactam ring: the shared chemical core of penicillins, cephalosporins, carbapenems and monobactams; it binds penicillin-binding proteins (PBPs) and stops cell-wall cross-linking, so the bacterium bursts.
• Beta-lactamase: bacterial enzymes that snap the beta-lactam ring open; countered by inhibitors like clavulanic acid, sulbactam and tazobactam.
• Cephalosporin generations: 1st (cefazolin, skin surgery prophylaxis) through 3rd (ceftriaxone, meningitis and gonorrhoea) to 5th (ceftaroline, active against MRSA).
• Macrolides: bind the 50S subunit and are bacteriostatic; azithromycin has a very long half-life allowing short courses; erythromycin and clarithromycin interact with many drugs through the CYP3A4 liver enzyme and can prolong the heart QT interval.
• Aminoglycosides: bind the 30S subunit, kill in a concentration-dependent way and keep killing after the drug level falls (post-antibiotic effect); they need oxygen to enter bacteria, so they fail against anaerobes; main toxicities are kidney damage and hearing damage.
• Quinolones: block DNA gyrase (mainly gram-negative target) and topoisomerase IV (mainly gram-positive target); ciprofloxacin suits urinary infections, levofloxacin and moxifloxacin suit respiratory infections

Formulas

• Aminoglycoside once-daily dose: 5 to 7 mg per kg body weight IV per day (extended-interval dosing).
• Gentamicin targets: peak 5 to 10 micrograms per mL, trough below 1 microgram per mL.

Worked Example

A 60 kg adult with a serious gram-negative infection is prescribed once-daily gentamicin. Step 1: dose = 5 mg/kg times 60 kg = 300 mg IV once daily. Step 2: draw a peak level 30 minutes after the infusion ends; it should read 5 to 10 micrograms per mL, confirming concentration-dependent killing. Step 3: draw a trough just before the next dose; it must be below 1 microgram per mL, confirming the kidneys have cleared the drug and toxicity risk is low. If the trough is high, the interval is stretched before the next dose rather than the dose being cut, because killing depends on a high peak.

Common Misconceptions

• "Antibiotics cure viral fevers and the common cold." Antibiotics cannot touch viruses; prescribing them for colds only breeds resistance and disturbs gut flora.
• "The newest, strongest antibiotic is always best." Narrow, targeted therapy cures while preserving broad agents like carbapenems for resistant infections; using the biggest gun first is how resistance spreads.
• "Stop the antibiotic once the fever settles." Stopping early leaves the toughest bacteria alive to regrow resistant. Complete the prescribed course unless the doctor changes it.

Real-World Applications

• Community pneumonia: a beta-lactam plus a macrolide covers both typical and atypical organisms.
• Urinary tract infections: nitrofurantoin or a quinolone for uncomplicated cystitis, guided by culture.
• Bacterial meningitis: ceftriaxone plus vancomycin empirically until cultures return.
• Surgical prophylaxis: single-dose cefazolin before incision prevents wound infections.
• Drug-resistant gram-negative sepsis: aminoglycoside or carbapenem combinations in intensive care.

Beta-lactams break the cell wall, macrolides stall the 50S ribosome, aminoglycosides corrupt the 30S ribosome in a concentration-dependent kill, and quinolones tangle bacterial DNA. Each family has signature uses and signature toxicities, from aminoglycoside hearing damage to quinolone tendon injury.